A detailed history of Plato Investment Management LTD transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Plato Investment Management LTD holds 4,561 shares of EW stock, worth $317,171. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,561
Previous 8,314 45.14%
Holding current value
$317,171
Previous $768 Million 60.85%
% of portfolio
0.02%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$59.7 - $93.78 $224,054 - $351,956
-3,753 Reduced 45.14%
4,561 $301 Million
Q2 2024

Aug 08, 2024

BUY
$84.3 - $94.31 $66,849 - $74,787
793 Added 10.54%
8,314 $768 Million
Q1 2024

May 14, 2024

BUY
$72.54 - $95.56 $495,158 - $652,292
6,826 Added 982.16%
7,521 $1.1 Billion
Q4 2023

Feb 12, 2024

BUY
$61.71 - $77.76 $42,888 - $54,043
695 New
695 $53 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $43B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Plato Investment Management LTD Portfolio

Follow Plato Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plato Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Plato Investment Management LTD with notifications on news.